Does SORAFENIB Cause Activated partial thromboplastin time prolonged? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Activated partial thromboplastin time prolonged have been filed in association with SORAFENIB (sorafenib). This represents 0.2% of all adverse event reports for SORAFENIB.
21
Reports of Activated partial thromboplastin time prolonged with SORAFENIB
0.2%
of all SORAFENIB reports
4
Deaths
2
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From SORAFENIB?
Of the 21 reports, 4 (19.0%) resulted in death, 2 (9.5%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SORAFENIB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which SORAFENIB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK